Clinical trial
Impact of IntraVascular UltraSound Guidance on the Outcomes of Xience Prime Stents in Long Lesions (IVUS-XPL Study): Retrospective and Prospective Follow-up Study
NCT03866486 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of IntraVascular UltraSound Guidance on the Outcomes of Xience Prime Stents in Long Lesions (IVUS-XPL Study): Retrospective and Prospective Follow-up Study
- Lead sponsor
- Yonsei University
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- March 15, 2019
- Completion date
- January 31, 2025
- Enrollment
- 1,400 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
myocardial ischemia(implanted drug-eluting stents because of ischemic heart disease(stable angina, acute coronary syndrome))